Vontobel Swiss Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vontobel Swiss Wealth Advisors's BMY Position: Q2 2021 in Review
Vontobel Swiss Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 4.7% in Q2 2021, buying an estimated $364K and bringing the position to 123,928 shares worth $8.11M. The position accounts for 4.17% of the portfolio, ranked #6.
Vontobel Swiss Wealth Advisors first reported a position in BMY in Q2 2019 and has held it in 9 quarters since. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Vontobel Swiss Wealth Advisors held 123,928 shares of Bristol-Myers Squibb worth $8.11M as of Q2 2021.
- Vontobel Swiss Wealth Advisors bought 5,582 Bristol-Myers Squibb shares in Q2 2021, an estimated $364K.
- Bristol-Myers Squibb made up 4.17% of Vontobel Swiss Wealth Advisors's portfolio in Q2 2021, its #6 holding.
- Vontobel Swiss Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 9 quarters since.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.